News Releases
April 28, 2011
The new treatment, known as radiofrequency ablation (RFA), was pioneered at Jefferson by Dr. Infantolino.
April 24, 2011
Researchers uncover role of GM-CSF, an inflammatory cytokine, in T helper cells; blocking it could treat multiple sclerosis.
April 19, 2011
Findings show that damage to surrounding tissue may play role in determining high-grade glioma patients' long-term outcome.
April 18, 2011
Jefferson Hospital for Neuroscience, first in tri-state area to use new device, can now better treat large aneurysms.
April 15, 2011
Kimmel Cancer Center at Jefferson researchers used gene signatures and energy metabolism to predict clinical outcome, rather than gene mutations.
April 12, 2011
Intense-modulated radiotherapy proves advantageous: a higher dose and less toxicity could lead to better outcomes.
April 07, 2011
Specialized knowledge will be gained regarding the care of two specific populations of breast cancer patients: the elderly and high-risk "triple negative" disease patients.